Company record
Pharming Group N.V.
- N.V.
- Leiden
- KVK 28048592
- NL0010391025
- Listed issuer
Size source: afm-register
Signals
174 on record
- AFM shortsNet short position
Citadel Securities (Europe) Limited net short position is 0.48% of Pharming Group N.V. (NL0010391025), down 0.11% from 0.59%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
Capstone Volatility Master (Cayman) Limited net short position is 0.84% of Pharming Group N.V. (NL0010391025), up 0.12% from 0.72%.
AFM shortsRelevance68
Medium · 95% confidence
- EuronextOther announcement
PHARMING GROUP: Pharming to participate in fireside chat at Jefferies Global Healthcare Conference in London. Topic: -. Industry: 20103015 Pharmaceuticals.
EuronextRelevance17
Watch · 80% confidence
- AFM shortsNet short position
Jane Street Group LLC net short position is 0.5% of Pharming Group N.V. (NL0010391025). First position for this holder and ISIN in the AFM export.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
Citadel Advisors LLC net short position is 0.99% of Pharming Group N.V. (NL0010391025), down 0.07% from 1.06%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
Citadel Advisors LLC net short position is 1.06% of Pharming Group N.V. (NL0010391025), down 0.09% from 1.15%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
Citadel Securities (Europe) Limited net short position is 0.59% of Pharming Group N.V. (NL0010391025), down 0.2% from 0.79%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
Citadel Advisors LLC net short position is 1.15% of Pharming Group N.V. (NL0010391025), down 0.14% from 1.29%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
D. E. Shaw & Co., L.P. net short position is 0.45% of Pharming Group N.V. (NL0010391025), down 0.13% from 0.58%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
D. E. Shaw & Co., L.P. net short position is 0.58% of Pharming Group N.V. (NL0010391025), down 0.1% from 0.68%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
Two Sigma Investments, LP net short position is 0.79% of Pharming Group N.V. (NL0010391025), down 0.07% from 0.86%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM stakesStake change
JP Morgan Chase & Co capital interest in Pharming Group N.V. is 4.9%, down from 5.16%. Threshold down through: 5%.
AFM stakesRelevance87
Medium · 93% confidence
- AFM shortsNet short position
Lazard Asset Management LLC net short position is 0.38% of Pharming Group N.V. (NL0010391025), down 0.12% from 0.5%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
Citadel Advisors LLC net short position is 1.29% of Pharming Group N.V. (NL0010391025), down 0.01% from 1.3%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
D. E. Shaw & Co., L.P. net short position is 0.68% of Pharming Group N.V. (NL0010391025), down 0.1% from 0.78%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
Two Sigma Investments, LP net short position is 0.86% of Pharming Group N.V. (NL0010391025), down 0.06% from 0.92%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
Citadel Securities (Europe) Limited net short position is 0.79% of Pharming Group N.V. (NL0010391025), down 0.01% from 0.8%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
Spark Investment Management LLC net short position is 0.48% of Pharming Group N.V. (NL0010391025), down 0.04% from 0.52%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
Citadel Advisors LLC net short position is 1.3% of Pharming Group N.V. (NL0010391025), up 0.03% from 1.27%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
Two Sigma Investments, LP net short position is 0.92% of Pharming Group N.V. (NL0010391025), down 0.16% from 1.08%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
Citadel Securities (Europe) Limited net short position is 0.8% of Pharming Group N.V. (NL0010391025), up 0.01% from 0.79%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
Walleye Capital LLC net short position is 0.42% of Pharming Group N.V. (NL0010391025), down 0.16% from 0.58%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM stakesStake change
JP Morgan Chase & Co capital interest in Pharming Group N.V. is 5.16%, down from 5.65%. No AFM threshold crossed.
AFM stakesRelevance87
Medium · 93% confidence
- AFM shortsNet short position
Two Sigma Investments, LP net short position is 1.08% of Pharming Group N.V. (NL0010391025), down 0.15% from 1.23%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
Two Sigma Investments, LP net short position is 1.23% of Pharming Group N.V. (NL0010391025), down 0.16% from 1.39%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
Jupiter Asset Management Ltd. net short position is 0.49% of Pharming Group N.V. (NL0010391025), down 0.02% from 0.51%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
D. E. Shaw & Co., L.P. net short position is 0.78% of Pharming Group N.V. (NL0010391025), down 0.1% from 0.88%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
Citadel Advisors LLC net short position is 1.27% of Pharming Group N.V. (NL0010391025), down 0.07% from 1.34%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
AQR Capital Management, LLC net short position is 0.49% of Pharming Group N.V. (NL0010391025), down 0.01% from 0.5%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
Walleye Capital LLC net short position is 0.58% of Pharming Group N.V. (NL0010391025), down 0.11% from 0.69%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
Lazard Asset Management LLC net short position is 0.5% of Pharming Group N.V. (NL0010391025), up 0.03% from 0.47%.
AFM shortsRelevance68
Medium · 95% confidence
- EuronextOther announcement
PHARMING GROUP: Pharming Group reports third quarter 2026 financial results; strong revenue growth, Joenja APDS expansion and CVID topline data in November. Topic: Commercial results. Industry: 20103015 Pharmaceuticals.
EuronextRelevance17
Watch · 80% confidence
- AFM shortsNet short position
D. E. Shaw & Co., L.P. net short position is 0.88% of Pharming Group N.V. (NL0010391025), down 0.08% from 0.96%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
Citadel Advisors LLC net short position is 1.34% of Pharming Group N.V. (NL0010391025), down 0.1% from 1.44%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
Two Sigma Investments, LP net short position is 1.39% of Pharming Group N.V. (NL0010391025), down 0.1% from 1.49%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM stakesStake change
Bank of America Corporation capital interest in Pharming Group N.V. is 2.97%, down from 3.73%. Threshold down through: 3%.
AFM stakesRelevance87
Medium · 93% confidence
- AFM shortsNet short position
Citadel Advisors LLC net short position is 1.44% of Pharming Group N.V. (NL0010391025), up 0.1% from 1.34%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
D. E. Shaw & Co., L.P. net short position is 0.96% of Pharming Group N.V. (NL0010391025), down 0.07% from 1.03%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM stakesStake change
Bank of America Corporation capital interest in Pharming Group N.V. is 3.73%, up from 3.22%. No AFM threshold crossed.
AFM stakesRelevance87
Medium · 93% confidence
- AFM shortsNet short position
Citadel Securities (Europe) Limited net short position is 0.79% of Pharming Group N.V. (NL0010391025), down 0.01% from 0.8%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
Citadel Securities (Europe) Limited net short position is 0.8% of Pharming Group N.V. (NL0010391025), up 0.13% from 0.67%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
D. E. Shaw & Co., L.P. net short position is 1.03% of Pharming Group N.V. (NL0010391025), down 0.07% from 1.1%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
Citadel Advisors LLC net short position is 1.34% of Pharming Group N.V. (NL0010391025), down 0.14% from 1.48%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
Walleye Capital LLC net short position is 0.69% of Pharming Group N.V. (NL0010391025), down 0.01% from 0.7%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
Two Sigma Investments, LP net short position is 1.49% of Pharming Group N.V. (NL0010391025), down 0.01% from 1.5%.
AFM shortsRelevance68
Medium · 95% confidence
- EuronextOther announcement
PHARMING GROUP: Pharming Group announces third quarter 2026 revenues above market expectations. Topic: Commercial results. Industry: 20103015 Pharmaceuticals.
EuronextRelevance17
Watch · 80% confidence
- AFM shortsNet short position
Walleye Capital LLC net short position is 0.7% of Pharming Group N.V. (NL0010391025), up 0.08% from 0.62%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
Citadel Securities (Europe) Limited net short position is 0.67% of Pharming Group N.V. (NL0010391025), down 0.04% from 0.71%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
Citadel Advisors LLC net short position is 1.48% of Pharming Group N.V. (NL0010391025), down 0.02% from 1.5%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
D. E. Shaw & Co., L.P. net short position is 1.1% of Pharming Group N.V. (NL0010391025), up 0.09% from 1.01%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
Citadel Securities (Europe) Limited net short position is 0.71% of Pharming Group N.V. (NL0010391025), up 0.08% from 0.63%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
Citadel Securities (Europe) Limited net short position is 0.63% of Pharming Group N.V. (NL0010391025), up 0.11% from 0.52%.
AFM shortsRelevance68
Medium · 95% confidence
- EuronextOther announcement
PHARMING GROUP: Pharming presents positive Phase II topline data for leniolisib in genetic PIDs with immune dysregulation at ESID 2026. Topic: Other subject. Industry: 20103015 Pharmaceuticals.
EuronextRelevance17
Watch · 80% confidence
- AFM shortsNet short position
GSA Capital Partners LLP net short position is 0.48% of Pharming Group N.V. (NL0010391025), down 0.02% from 0.5%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
Citadel Advisors LLC net short position is 1.5% of Pharming Group N.V. (NL0010391025), up 0.04% from 1.46%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM stakesStake change
Bank of America Corporation capital interest in Pharming Group N.V. is 3.22%, down from 3.29%. No AFM threshold crossed.
AFM stakesRelevance87
Medium · 93% confidence
- AFM shortsNet short position
Citadel Securities (Europe) Limited net short position is 0.52% of Pharming Group N.V. (NL0010391025), up 0.08% from 0.44%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM stakesStake change
Barclays Plc capital interest in Pharming Group N.V. is 2.57%, down from 3.38%. Threshold down through: 3%.
AFM stakesRelevance87
Medium · 93% confidence
- AFM shortsNet short position
Citadel Advisors LLC net short position is 1.46% of Pharming Group N.V. (NL0010391025), down 0.05% from 1.51%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
D. E. Shaw & Co., L.P. net short position is 1.01% of Pharming Group N.V. (NL0010391025), up 0.11% from 0.9%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM stakesStake change
Bank of America Corporation capital interest in Pharming Group N.V. is 3.29%, up from 2.92%. Threshold crossed: 3%.
AFM stakesRelevance87
Medium · 93% confidence
- AFM shortsNet short position
AQR Capital Management, LLC net short position is 0.5% of Pharming Group N.V. (NL0010391025), up 0.02% from 0.48%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM stakesStake change
Barclays Plc capital interest in Pharming Group N.V. is 3.38%, up from 2.03%. Threshold crossed: 3%.
AFM stakesRelevance87
Medium · 93% confidence
- AFM shortsNet short position
Citadel Advisors LLC net short position is 1.51% of Pharming Group N.V. (NL0010391025), up 0.02% from 1.49%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
Citadel Advisors LLC net short position is 1.49% of Pharming Group N.V. (NL0010391025), down 0.05% from 1.54%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
D. E. Shaw & Co., L.P. net short position is 0.9% of Pharming Group N.V. (NL0010391025), up 0.09% from 0.81%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
GSA Capital Partners LLP net short position is 0.5% of Pharming Group N.V. (NL0010391025), up 0.02% from 0.48%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
Two Sigma Investments, LP net short position is 1.5% of Pharming Group N.V. (NL0010391025), up 0.06% from 1.44%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
GSA Capital Partners LLP net short position is 0.48% of Pharming Group N.V. (NL0010391025), down 0.02% from 0.5%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
Two Sigma Investments, LP net short position is 1.44% of Pharming Group N.V. (NL0010391025), up 0.14% from 1.3%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
D. E. Shaw & Co., L.P. net short position is 0.81% of Pharming Group N.V. (NL0010391025), up 0.11% from 0.7%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM capitalCapital change
Issued capital of Pharming Group N.V.: 708,297,390 shares, up 516,150 from 707,781,240 (+0.1%). Share issue.
AFM capitalRelevance50
Watch · 93% confidence
- EuronextExecutive change
PHARMING GROUP: Pharming announces CEO transition. Topic: Journal / appointments. Industry: 20103015 Pharmaceuticals.
EuronextRelevance41
Medium · 80% confidence
- AFM shortsNet short position
Citadel Advisors LLC net short position is 1.54% of Pharming Group N.V. (NL0010391025), up 0.07% from 1.47%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
Walleye Capital LLC net short position is 0.62% of Pharming Group N.V. (NL0010391025), up 0.03% from 0.59%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
Two Sigma Investments, LP net short position is 1.3% of Pharming Group N.V. (NL0010391025), up 0.02% from 1.28%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
AQR Capital Management, LLC net short position is 0.48% of Pharming Group N.V. (NL0010391025), down 0.03% from 0.51%.
AFM shortsRelevance68
Medium · 95% confidence
- EuronextOther announcement
PHARMING GROUP: Pharming announces U.S. FDA acceptance and Priority Review of sNDA for lower doses of Joenja® to treat children with APDS. Topic: Commercial operations. Industry: 20103015 Pharmaceuticals.
EuronextRelevance17
Watch · 80% confidence
- AFM shortsNet short position
Citadel Advisors LLC net short position is 1.47% of Pharming Group N.V. (NL0010391025), down 0.03% from 1.5%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
D. E. Shaw & Co., L.P. net short position is 0.7% of Pharming Group N.V. (NL0010391025), up 0.05% from 0.65%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
Lazard Asset Management LLC net short position is 0.47% of Pharming Group N.V. (NL0010391025), down 0.12% from 0.59%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
Citadel Advisors LLC net short position is 1.5% of Pharming Group N.V. (NL0010391025), up 0.07% from 1.43%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
Lazard Asset Management LLC net short position is 0.59% of Pharming Group N.V. (NL0010391025), down 0.01% from 0.6%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM stakesStake change
UBS Group AG capital interest in Pharming Group N.V. is 2.86%, down from 3.05%. Threshold down through: 3%.
AFM stakesRelevance87
Medium · 93% confidence
- AFM shortsNet short position
GSA Capital Partners LLP net short position is 0.5% of Pharming Group N.V. (NL0010391025), up 0.01% from 0.49%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
Lazard Asset Management LLC net short position is 0.6% of Pharming Group N.V. (NL0010391025), up 0.01% from 0.59%.
AFM shortsRelevance68
Medium · 95% confidence
- EuronextOther announcement
PHARMING GROUP: Pharming announces positive Phase II topline data for leniolisib in PIDs with immune dysregulation accepted as late-breaking abstract at ESID 2026. Topic: Other subject. Industry: 20103015 Pharmaceuticals.
EuronextRelevance17
Watch · 80% confidence
- AFM shortsNet short position
Walleye Capital LLC net short position is 0.59% of Pharming Group N.V. (NL0010391025), down 0.08% from 0.67%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
Citadel Advisors LLC net short position is 1.43% of Pharming Group N.V. (NL0010391025), up 0.12% from 1.31%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM stakesStake change
UBS Group AG capital interest in Pharming Group N.V. is 3.05%, up from 2.6%. Threshold crossed: 3%.
AFM stakesRelevance87
Medium · 93% confidence
- AFM shortsNet short position
D. E. Shaw & Co., L.P. net short position is 0.65% of Pharming Group N.V. (NL0010391025), down 0.05% from 0.7%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM stakesStake change
BlackRock Inc. capital interest in Pharming Group N.V. is 3%, up from 2.99%. Voting rights 3.35%, up from 3.33%. Threshold crossed: 3%.
AFM stakesRelevance87
Medium · 93% confidence
- AFM shortsNet short position
Citadel Advisors LLC net short position is 1.31% of Pharming Group N.V. (NL0010391025), up 0.11% from 1.2%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
D. E. Shaw & Co., L.P. net short position is 0.7% of Pharming Group N.V. (NL0010391025), up 0.01% from 0.69%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
Walleye Capital LLC net short position is 0.67% of Pharming Group N.V. (NL0010391025), down 0.1% from 0.77%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
Citadel Advisors LLC net short position is 1.2% of Pharming Group N.V. (NL0010391025), up 0.2% from 1%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
Jupiter Asset Management Ltd. net short position is 0.51% of Pharming Group N.V. (NL0010391025), up 0.04% from 0.47%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
AQR Capital Management, LLC net short position is 0.51% of Pharming Group N.V. (NL0010391025). First position for this holder and ISIN in the AFM export.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
Capstone Volatility Master (Cayman) Limited net short position is 0.72% of Pharming Group N.V. (NL0010391025), down 0.08% from 0.8%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
Walleye Capital LLC net short position is 0.77% of Pharming Group N.V. (NL0010391025), down 0.09% from 0.86%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM stakesStake change
BlackRock Inc. capital interest in Pharming Group N.V. is 2.99%, down from 3.02%. Voting rights 3.33%, down from 3.38%. Threshold down through: 3%.
AFM stakesRelevance87
Medium · 93% confidence
- AFM stakesStake change
Goldman Sachs Group Inc., The capital interest in Pharming Group N.V. is 2.66%, down from 3%. Threshold down through: 3%.
AFM stakesRelevance87
Medium · 93% confidence
- AFM shortsNet short position
Lazard Asset Management LLC net short position is 0.59% of Pharming Group N.V. (NL0010391025), down 0.01% from 0.6%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM stakesStake change
Goldman Sachs Group Inc., The capital interest in Pharming Group N.V. is 3%, up from 2.89%. Threshold crossed: 3%.
AFM stakesRelevance87
Medium · 93% confidence
- AFM shortsNet short position
Walleye Capital LLC net short position is 0.86% of Pharming Group N.V. (NL0010391025), down 0.09% from 0.95%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
Two Sigma Investments, LP net short position is 1.28% of Pharming Group N.V. (NL0010391025), down 0.1% from 1.38%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM stakesStake change
Millennium International Management LP capital interest in Pharming Group N.V. is 2.96%, down from 3.01%. Threshold down through: 3%.
AFM stakesRelevance87
Medium · 93% confidence
- AFM stakesStake change
Millennium International Management LP capital interest in Pharming Group N.V. is 3.01%. First position in the AFM export, at or above the 3% threshold.
AFM stakesRelevance87
Medium · 93% confidence
- AFM shortsNet short position
Marshall Wace LLP net short position is 0.48% of Pharming Group N.V. (NL0010391025), down 0.1% from 0.58%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
Citadel Advisors LLC net short position is 1% of Pharming Group N.V. (NL0010391025), up 0.03% from 0.97%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
Walleye Capital LLC net short position is 0.95% of Pharming Group N.V. (NL0010391025), down 0.05% from 1%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM stakesStake change
Goldman Sachs Group Inc., The capital interest in Pharming Group N.V. is 2.89%, down from 3.1%. Threshold down through: 3%.
AFM stakesRelevance87
Medium · 93% confidence
- AFM shortsNet short position
Citadel Advisors LLC net short position is 0.97% of Pharming Group N.V. (NL0010391025), down 0.07% from 1.04%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
Marshall Wace LLP net short position is 0.58% of Pharming Group N.V. (NL0010391025), down 0.09% from 0.67%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM stakesStake change
Goldman Sachs Group Inc., The capital interest in Pharming Group N.V. is 3.1%, down from 3.11%. No AFM threshold crossed.
AFM stakesRelevance87
Medium · 93% confidence
- AFM stakesStake change
Goldman Sachs Group Inc., The capital interest in Pharming Group N.V. is 3.11%, up from 2.94%. Threshold crossed: 3%.
AFM stakesRelevance87
Medium · 93% confidence
- AFM shortsNet short position
Marshall Wace LLP net short position is 0.67% of Pharming Group N.V. (NL0010391025), down 0.07% from 0.74%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
Two Sigma Investments, LP net short position is 1.38% of Pharming Group N.V. (NL0010391025), down 0.1% from 1.48%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
Marshall Wace LLP net short position is 0.74% of Pharming Group N.V. (NL0010391025), down 0.11% from 0.85%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM stakesStake change
Goldman Sachs Group Inc., The capital interest in Pharming Group N.V. is 2.94%, down from 3.06%. Threshold down through: 3%.
AFM stakesRelevance87
Medium · 93% confidence
- AFM shortsNet short position
Marshall Wace LLP net short position is 0.85% of Pharming Group N.V. (NL0010391025), down 0.06% from 0.91%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
Qube Research & Technologies Ltd. net short position is 0.49% of Pharming Group N.V. (NL0010391025), down 0.07% from 0.56%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
Marshall Wace LLP net short position is 0.91% of Pharming Group N.V. (NL0010391025), up 0.03% from 0.88%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
Two Sigma Investments, LP net short position is 1.48% of Pharming Group N.V. (NL0010391025), down 0.11% from 1.59%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
Walleye Capital LLC net short position is 1% of Pharming Group N.V. (NL0010391025), up 0.01% from 0.99%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
Citadel Advisors LLC net short position is 1.04% of Pharming Group N.V. (NL0010391025), up 0.14% from 0.9%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
D. E. Shaw & Co., L.P. net short position is 0.69% of Pharming Group N.V. (NL0010391025), down 0.07% from 0.76%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
Citadel Advisors LLC net short position is 0.9% of Pharming Group N.V. (NL0010391025), up 0.02% from 0.88%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
Capstone Volatility Master (Cayman) Limited net short position is 0.8% of Pharming Group N.V. (NL0010391025), up 0.03% from 0.77%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
Qube Research & Technologies Ltd. net short position is 0.56% of Pharming Group N.V. (NL0010391025), down 0.06% from 0.62%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
Citadel Advisors LLC net short position is 0.88% of Pharming Group N.V. (NL0010391025), down 0.04% from 0.92%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
D. E. Shaw & Co., L.P. net short position is 0.76% of Pharming Group N.V. (NL0010391025), down 0.11% from 0.87%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
Lazard Asset Management LLC net short position is 0.6% of Pharming Group N.V. (NL0010391025), up 0.04% from 0.56%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
Marshall Wace LLP net short position is 0.88% of Pharming Group N.V. (NL0010391025), down 0.06% from 0.94%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
Capstone Volatility Master (Cayman) Limited net short position is 0.77% of Pharming Group N.V. (NL0010391025), up 0.08% from 0.69%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
Two Sigma Investments, LP net short position is 1.59% of Pharming Group N.V. (NL0010391025), down 0.04% from 1.63%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
Citadel Advisors LLC net short position is 0.92% of Pharming Group N.V. (NL0010391025), up 0.07% from 0.85%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM stakesStake change
Goldman Sachs Group Inc., The capital interest in Pharming Group N.V. is 3.06%, up from 2.79%. Threshold crossed: 3%.
AFM stakesRelevance87
Medium · 93% confidence
- AFM shortsNet short position
D. E. Shaw & Co., L.P. net short position is 0.87% of Pharming Group N.V. (NL0010391025), down 0.1% from 0.97%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM stakesStake change
Goldman Sachs Group Inc., The capital interest in Pharming Group N.V. is 2.79%, down from 3.71%. Threshold down through: 3%.
AFM stakesRelevance87
Medium · 93% confidence
- AFM shortsNet short position
Walleye Capital LLC net short position is 0.99% of Pharming Group N.V. (NL0010391025), down 0.06% from 1.05%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
Citadel Advisors LLC net short position is 0.85% of Pharming Group N.V. (NL0010391025), up 0.07% from 0.78%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM stakesStake change
Bank of America Corporation capital interest in Pharming Group N.V. is 2.92%, down from 3.1%. Threshold down through: 3%.
AFM stakesRelevance87
Medium · 93% confidence
- AFM shortsNet short position
Walleye Capital LLC net short position is 1.05% of Pharming Group N.V. (NL0010391025), down 0.16% from 1.21%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
Citadel Advisors LLC net short position is 0.78% of Pharming Group N.V. (NL0010391025), up 0.11% from 0.67%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM stakesStake change
Bank of America Corporation capital interest in Pharming Group N.V. is 3.1%, up from 2.41%. Threshold crossed: 3%.
AFM stakesRelevance87
Medium · 93% confidence
- AFM insidersInsider transaction
Breidenbach A. (Chief Business Officer) bought 50,000 gewoon aandeel at 0.91 EUR (NL0010391025) in Pharming Group N.V.
AFM insidersRelevance45
Medium · 94% confidence
- AFM shortsNet short position
Citadel Advisors LLC net short position is 0.67% of Pharming Group N.V. (NL0010391025), up 0.1% from 0.57%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
Marshall Wace LLP net short position is 0.94% of Pharming Group N.V. (NL0010391025), up 0.12% from 0.82%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
D. E. Shaw & Co., L.P. net short position is 0.97% of Pharming Group N.V. (NL0010391025), up 0.15% from 0.82%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
D. E. Shaw & Co. (London), LLP net short position is 0.46% of Pharming Group N.V. (NL0010391025), down 0.04% from 0.5%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM stakesStake change
Goldman Sachs Group Inc., The capital interest in Pharming Group N.V. is 3.71%, up from 2.98%. Threshold crossed: 3%.
AFM stakesRelevance87
Medium · 93% confidence
- AFM shortsNet short position
Citadel Advisors LLC net short position is 0.57% of Pharming Group N.V. (NL0010391025), up 0.09% from 0.48%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
Two Sigma Investments, LP net short position is 1.63% of Pharming Group N.V. (NL0010391025), up 0.07% from 1.56%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
Marshall Wace LLP net short position is 0.82% of Pharming Group N.V. (NL0010391025), up 0.03% from 0.79%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
Citadel Securities (Europe) Limited net short position is 0.44% of Pharming Group N.V. (NL0010391025), down 0.25% from 0.69%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
Qube Research & Technologies Ltd. net short position is 0.62% of Pharming Group N.V. (NL0010391025), up 0.05% from 0.57%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
D. E. Shaw & Co., L.P. net short position is 0.82% of Pharming Group N.V. (NL0010391025), up 0.2% from 0.62%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
Two Sigma Investments, LP net short position is 1.56% of Pharming Group N.V. (NL0010391025), up 0.1% from 1.46%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
Citadel Securities (Europe) Limited net short position is 0.69% of Pharming Group N.V. (NL0010391025), down 0.1% from 0.79%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
Marshall Wace LLP net short position is 0.79% of Pharming Group N.V. (NL0010391025), down 0.01% from 0.8%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
Citadel Advisors LLC net short position is 0.48% of Pharming Group N.V. (NL0010391025), down 0.06% from 0.54%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
Lazard Asset Management LLC net short position is 0.56% of Pharming Group N.V. (NL0010391025), down 0.11% from 0.67%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
Marshall Wace LLP net short position is 0.8% of Pharming Group N.V. (NL0010391025), up 0.36% from 0.44%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
Qube Research & Technologies Ltd. net short position is 0.57% of Pharming Group N.V. (NL0010391025), up 0.08% from 0.49%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
Citadel Advisors LLC net short position is 0.54% of Pharming Group N.V. (NL0010391025), up 0.08% from 0.46%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
Two Sigma Investments, LP net short position is 1.46% of Pharming Group N.V. (NL0010391025), up 0.25% from 1.21%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
Citadel Securities (Europe) Limited net short position is 0.79% of Pharming Group N.V. (NL0010391025), up 0.38% from 0.41%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
Capstone Volatility Master (Cayman) Limited net short position is 0.69% of Pharming Group N.V. (NL0010391025), down 0.14% from 0.83%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
D. E. Shaw & Co., L.P. net short position is 0.62% of Pharming Group N.V. (NL0010391025), up 0.44% from 0.18%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
Lazard Asset Management LLC net short position is 0.67% of Pharming Group N.V. (NL0010391025), down 0.06% from 0.73%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM stakesStake change
JP Morgan Chase & Co capital interest in Pharming Group N.V. is 5.65%, up from 5.38%. No AFM threshold crossed.
AFM stakesRelevance87
Medium · 93% confidence
- AFM shortsNet short position
Two Sigma Investments, LP net short position is 1.21% of Pharming Group N.V. (NL0010391025), up 0.11% from 1.1%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
Walleye Capital LLC net short position is 1.21% of Pharming Group N.V. (NL0010391025), up 0.11% from 1.1%.
AFM shortsRelevance68
Medium · 95% confidence